References
- Kruse-Jarres R, Kempton CL, Baudo F, et al. Acquired hemophilia A: updated review of evidence and treatment guidance. Am J Hematol. 2017;92(7):695–705. doi:https://doi.org/10.1002/ajh.24777.
- Collins P, Macartney N, Davies R, Lees S, Giddings J, Majer R. A population based, unselected, consecutive cohort of patients with acquired haemophilia A. Br J Haematol. 2004;124(1):86–90. doi:https://doi.org/10.1046/j.1365-2141.2003.04731.x.
- Knoebl P, Marco P, Baudo F, et al. Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2). J Thromb Haemost. 2012;10(4):622–631. doi:https://doi.org/10.1111/j.1538-7836.2012.04654.x.
- Arthanari S, Ahmad H, Nisar M. Fatal acquired hemophilia a in a patient with rheumatoid arthritis treated with adalimumab. J Clin Rheumatol. 2012;18(1):50–51. doi:https://doi.org/10.1097/RHU.0b013e31823ee3cd.
- Yamaguchi T, Itoh M, Umezawa Y, Asahina A, Hanabusa H, Nakagawa H. Acquired hemophilia A and fulminant diabetes mellitus possibly caused by adalimumab in a patient with psoriatic arthritis. J Dermatol. 2017;44(3):e3–e4. doi:https://doi.org/10.1111/1346-8138.13468.
- Baudo F, Collins P, Huth-Kühne A, et al. Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry. Blood. 2012;120(1):39–46. doi:https://doi.org/10.1182/blood-2012-02-408930.
- Lossing TS, Kasper CK, Feinstein DI. Detection of factor VIII inhibitors with the partial thromboplastin time. Blood. 1977;49(5):793–797. doi:https://doi.org/10.1182/blood.V49.5.793.793.
- Clatworthy MR, Jayne DRW. Acquired hemophilia in association with ANCA-associated vasculitis: response to rituximab. Am J Kidney Dis. 2006;47(4):680–682. doi:https://doi.org/10.1053/j.ajkd.2006.01.009.
- Ramos-Casals M, Brito-Zerón P, Soto M-J, Cuadrado M-J, Khamashta MA. Autoimmune diseases induced by TNF-targeted therapies. Best Pract Res Clin Rheumatol. 2008;22(5):847–861. doi:https://doi.org/10.1016/j.berh.2008.09.008.
- Atzeni F, Talotta R, Salaffi F, et al. Immunogenicity and autoimmunity during anti-TNF therapy. Autoimmun Rev. 2013;12(7):703–708. doi:https://doi.org/10.1016/j.autrev.2012.10.021.
- Via CS, Shustov A, Rus V, Lang T, Nguyen P, Finkelman FD. In Vivo Neutralization of TNF-α Promotes Humoral Autoimmunity by Preventing the Induction of CTL. J Immunol. 2001;167(12):6821–6826. doi:https://doi.org/10.4049/jimmunol.167.12.6821.
- Sellam J, Allanore Y, Batteux F, Deslandre CJ, Weill B, Kahan A. Autoantibody induction in patients with refractory spondyloarthropathy treated with infliximab and methotrexate. Joint Bone Spine. 2005;72(1):48–52. doi:https://doi.org/10.1016/j.jbspin.2004.03.003.